Global Antidepressant Trends in 2024
Antidepressant is part of Therapy and includes a number of sub-sectors such as Serotonin Noradrenaline Reuptake Inhibitor, Monoamine Oxydase Inhibitor, Tricyclic Antidepressant and Serotonin Specific Reuptake Inhibitor. You may also be interested in Anesthetics, Anti-Infective and Cardiovascular Drug.
Global sales of antidepressant medication are projected to reach approximately $3.1 billion by 2028, down from $3.2 billion in 2023. This marks a modest average annual growth rate of 0.2%. Since 2019, the global market for antidepressants has seen a yearly increase of about 1.9%. In 2023, Germany led the market with sales totaling around $888 million. Following Germany, Spain, Italy, and Australia ranked second, third, and fourth, respectively. Notably, South Korea experienced a significant year-on-year growth of 9.1% in antidepressant sales, while Denmark saw a decline of 10.6% annually since 2019.
Top 5 countries
In 2024 major markets in the Antidepressant Industry were:
